{
  "id": 4795492,
  "title": "Indonesia Moves to Curb Drug Patent 'Evergreening': What to Know",
  "url": "https://urgent.news/2026/09/01/indonesia-moves-to-curb-drug-patent-evergreening-what-to-know",
  "topic": "world",
  "section": "World",
  "published": "2026-09-01T05:36:43.000Z",
  "source": {
    "name": "Tempo.co English",
    "slug": "tempo-co-english",
    "url": "https://en.tempo.co/read/2118698/indonesia-moves-to-curb-drug-patent-evergreening-what-to-know"
  },
  "original_language": "en",
  "account": "Indonesia's Constitutional Court has reinstated a provision that aims to curb drug patent evergreening, a practice that extends patent protection without significant innovation. This decision could help prevent pharmaceutical companies from monopolizing existing medicines and keep generic alternatives accessible. The ruling has been welcomed by patient advocacy groups who argue that it would make medicines more affordable and accessible to patients.",
  "summary": "Indonesia's Constitutional Court has revived limits on drug patent claims. Here's what the ruling means for generic medicines and access to treatment.",
  "key_points": [
    "Indonesia's Constitutional Court reinstates provision to curb drug patent evergreening.",
    "Practice extends patent protection without significant innovation.",
    "Patient advocacy groups welcome ruling for more affordable and accessible medicines."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}